Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients.

Akiyuki Uzawa Masahiro MoriHiroki MasudaTomohiko UchidaMayumi MutoRyohei OhtaniShinji AoyamaSatoshi Kuwabara

Published in: Journal of neurology, neurosurgery, and psychiatry (2024)

AQP4Ab+NMOSD is a severely disabling disease. Treatment interventions using prednisolone and biologics are useful in suppressing disability progression in AQP4Ab+NMOSD.

Keyphrases

spectrum disorder
multiple sclerosis
physical activity
signaling pathway
combination therapy
replacement therapy